Deprescribing Resources
- Acetylcholinesterase-inhibitors
- Anticholinergic drugs
- Antidepressants
- Antihypertensives
- Antipsychotics
- Allergy and Anaphylaxis drugs
- Antigout (Allopurinol/Antihyperuricemics)
- Antihyperglycemics
- Aspirin
- Benzodiazepines
- Bisphosphonates
- Glaucoma-eye-drops
- Non-selective NSAIDs and cox-2-selective NSAID
- Opioids
- Proton pump inhibitors (PPI)
- Statins
- Vitamin D & Calcium
Papers
- Linking Patients’ Goals and Priorities to Recommendations for Medication Changes in a Polypharmacy-Focused Structured Clinical Pathway (2023): When we incorporated into TAPER how well do the recommendations map onto the patient’s priorities that were recorded in TaperMD – around half the time the recommendations mapped directly to a patient priority (which is amazing!)
- A Proposed Curricular Framework for an Interprofessional Approach to Deprescribing (2023)
- Deprescribing to optimise health outcomes for frail older people: a double-blind placebo-controlled randomised controlled trial—outcomes of the Opti-med study (2023)
- I think this medicine actually killed my wife’: patient and family perspectives on shared decision-making to optimize medications and safety (2019)
- Making patient values visible in healthcare: a systematic review of tools to assess patient treatment priorities and preferences in the context of multimorbidity (2016): systematic review publication – seeing if anyone had already operationalized in a way suitable for multimorbidity/polypharmacy. Answer was no-one is doing it.
YouTube Videos
- Prescribe for Impact (2023)
- Breaking Up Can Be Hard To Do (2022)